Iridium complex constructed based on 8-hydroxyquinoline derivative and 1-phenylpyrazole iridium dimer as well as synthesis method and application of iridium complex
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 煌途医药(无锡)有限公司
- Publication Date
- 2020-05-08
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to an iridium complex constructed on the basis of 8-hydroxyquinoline derivatives and 1-phenylpyrazole iridium dimer and its synthesis method and application, belonging to the technical field of medicine. Background technique
[0002] Cancer is one of the most serious malignant diseases threatening human life and health. At present, more than three million people die of cancer every year in our country, which has seriously threatened the life and health of our people. Platinum complexes such as cisplatin are currently one of the most widely used chemotherapeutic drugs and one of the first-choice drugs for the treatment of many cancers (Lippard, S.J.; et al. Chem. Sci., 2015, 6, 1189–1193.). However, the extensive use of platinum-based drugs such as cisplatin in clinical practice can easily lead to drug resistance and severe side effects such as nephrotoxicity, neurotoxicity and bone marrow suppression, which greatly limit their th...